ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,823.20
      -0.11%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      83.315
      -1.22%
      Bitcoin
      65,129.72
      0.43%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Celadon Pharmaceuticals Plc (CEL) Quote

      Celadon Pharmaceuticals Plc

      Celadon Pharmaceuticals Plc (CEL)

      Challenger Gold Limited
      61.20
      0.70
      (1.16%)
      Closed July 16 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      61.20
      Bid
      55.00
      Ask
      60.00
      Volume
      209,157
      57.50 Day's Range 61.50
      57.50 52 Week Range 160.00
      Market Cap
      39.92M
      Previous Close
      60.50
      Open
      61.50
      Last Trade
      70000
      @
      58
      (O)
      Last Trade Time
      Financial Volume
      128,004p
      VWAP
      61.20
      Average Volume (3m)
      43,026
      Shares Outstanding
      65,982,712
      Dividend Yield
      -
      PE Ratio
      -5.31
      Earnings Per Share (EPS)
      -0.11
      Revenue
      149k
      Net Profit
      -7.14M

      About Celadon Pharmaceuticals Plc

      Sector
      Investment Advice
      Industry
      Investment Advice
      Website
      celadonpharma.co.uk
      Headquarters
      London, Gbr
      Founded
      1970
      Celadon Pharmaceuticals Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 60.50p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 57.50p to 160.00p.

      Celadon Pharmaceuticals currently has 65,982,712 shares outstanding. The market capitalization of Celadon Pharmaceuticals is £39.92 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.31.

      CEL Latest News

      More News

      EARNINGS AND TRADING: Gateley earnings fall; 4Global revenue rises

      The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

      5 hours ago
      Alliance News

      Celadon Pharmaceuticals PLC Successful Completion of Eighth Harvest of 2024

      Celadon Pharmaceuticals PLC 16 July 2024     Celadon Pharmaceuticals Plc   ("Celadon", the "Group" or the "Company")   Successful completion of eighth harvest of 2024   On track for fifteen...

      18 hours ago
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Third Admission of Shares

      Celadon Pharmaceuticals PLC 15 July 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company" or the "Group")   Third Admission of Shares   London, 15 July 2024 - Celadon...

      July 15 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Result of AGM

      Celadon Pharmaceuticals PLC 28 June 2024     Celadon Pharmaceuticals Plc   ("Celadon" or the "Company")   Result of Annual General Meeting   London, UK, 28 June 2024: Celadon Pharmaceuticals...

      June 28 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Second Admission of Shares

      Celadon Pharmaceuticals PLC 07 June 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company" or the "Group")   Second Admission of Shares   London, 07 June 2024 - Celadon...

      June 07 2024
      RNS Regulatory News

      ...

      June 03 2024
      Alliance News

      Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM

      Celadon Pharmaceuticals PLC 03 June 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company")    Publication of Annual Report and Notice of Annual General Meeting   London, 3 June...

      June 03 2024
      RNS Regulatory News

      TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

      The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

      May 23 2024
      Alliance News

      Celadon Pharmaceuticals PLC Supply of Products to New US Customer

      Celadon Pharmaceuticals PLC 23 May 2024     Celadon Pharmaceuticals Plc   ("Celadon", or the "Company")   Supply of Cannabis-Based Products to New US Customer London, 23 May 2024 - Celadon...

      May 23 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights

      Celadon Pharmaceuticals PLC 15 May 2024     Celadon Pharmaceuticals Plc   ("Celadon", or the "Company")   Exercise of Share Options and Total Voting Rights   London, 15 May 2024 - Celadon...

      May 15 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-13.8-18.4757557.54697862.32019745DE
      4-16.8-21.5384615385787957.54252172.50016168DE
      12-53.8-46.7826086957115117.557.54302684.39881738DE
      26-34.8-36.259612057.54391592.57608302DE
      52-83.8-57.793103448314516057.533669100.28019422DE
      156-123.8-66.9189189189185185494655598.93950614DE
      260-37.8-38.1818181818993304949927132.66673026DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SHIMShimmick Corporation
      $ 3.14
      (51.69%)
      		3.41M
      AFARAura FAT Projects Acquisition Corporation
      $ 16.97
      (35.76%)
      		61.44k
      AFARUAura FAT Projects Acquisition Corporation
      $ 16.50
      (33.82%)
      		1.73k
      AREBAmerican Rebel Holdings Inc
      $ 0.7952
      (15.25%)
      		2.51M
      ASSTAsset Entities Inc
      $ 1.79
      (14.01%)
      		638.99k
      ASPSAltisource Portfolio Solutions SA
      $ 1.2517
      (-9.95%)
      		4.12k
      RNLXRenalytix PLC
      $ 0.31
      (-9.86%)
      		31.14k
      FIVEFive Below Inc
      $ 92.09
      (-9.78%)
      		601.25k
      MGRXMangoceuticals Inc
      $ 0.3912
      (-9.02%)
      		130.35k
      LVTXLAVA Therapeutics NV
      $ 1.92
      (-9.00%)
      		2.39k
      MAXNMaxeon Solar Technologies Ltd
      $ 0.23895
      (-5.33%)
      		21.15M
      TKLFYoshitsu Company Ltd
      $ 0.576
      (-7.54%)
      		9.57M
      AGRIAgriFORCE Growing Systems Ltd
      $ 0.0807
      (-6.38%)
      		8.09M
      SILOSilo Pharma Inc
      $ 2.38
      (-0.42%)
      		5.28M
      SIRISirius XM Holdings Inc
      $ 3.84
      (-1.03%)
      		4.03M

      Discussion

      View Full Feed
      kund kund 2 minutes ago
      They were never removed from website, but their name has been removed from presentation deck.
      AVXL
      Joemags Joemags 2 minutes ago
      Haven’t gotten one of these in a while

      Epiq 11 Alert: Aegean Marine Petroleum N. #825 - Chapter 11 Post-Confirmation Report for the Quarte on 07/16/2024 http://dm.epiq11.com/case/AES/dockets/825?debtorId=7258 Reply STOP AES to stop alerts from this case.
      236T568 236T568 2 minutes ago
      Yikes, she admitted that she was drunk at the Baseball All-Star HR derby event

      https://www.youtube.com/watch?v=WjSiCqLUr7A
      wooqa wooqa 3 minutes ago
      ATCLF .0011
      ATCLF
      apr1 apr1 3 minutes ago
      GME AH getting ready for squeeze
      GME
      Stock_Barber Stock_Barber 3 minutes ago
      getting worried too much
      I don't blame you for being worried!

      💩🤡
      DBMM
      Brucebannerr Brucebannerr 4 minutes ago
      Pumping clowns move on to the next loser ? Lmfao!
      FSRNQ
      KenKong KenKong 4 minutes ago
      Watch and learn
      FNMA
      dinogreeves dinogreeves 4 minutes ago
      Trendtrader2016 is a weak trader who is afraid of his shadow and you are a CrossDresser, I don't know if they go hand in hand, but the laws in this Country about to change next year, better decide on your faith come next year.
      KOSS
      Involuntary-Recluse Involuntary-Recluse 5 minutes ago
      At most we get lucky and see a quarter for 100 shares 😂
      Run will be done in one session imho....
      ASKH
      Moonlazer Moonlazer 5 minutes ago
      Part of the issue that put inflation where it's at is cost of goods, services, and transportation costs. Terrifs cause this. Yeah, social structure spending and foreign wars do too, but a more restrictive market, especially while the rates are high, will have a bad effect on this economy. Everyon
      SPY
      logger-man logger-man 5 minutes ago
      Scheffler, DeChambeau, Morikawa, Burns, and Cam Smith. 275
      thank you.
      Jaxon2010 Jaxon2010 6 minutes ago
      Meant he can buy me a place soon! Lolzzz

      Was answering a pm fisherman.

      All good here bud.
      IGPK
      johnglenn johnglenn 6 minutes ago
      https://glucurve.ca/

      Is this new or did I miss it?
      ALRTF
      SoxFan SoxFan 6 minutes ago
      It's not a vaccine? Wow and now you have delusions you're a medical scientist. Like Trump you must think you're really really smart. Have you had any therapy to help you navigate through life?
      soundincrest soundincrest 6 minutes ago
      Podas, you never have anything good to say. You go away for 19 days . Coop down $2.98 afterhours on a 194 SHARES TRADE ?? Go back to bed
      COOP
      valuemind valuemind 7 minutes ago
      I bought TKLF today, ALAR yesterday, cwlpf last Friday and sezl last Thursday...
      TKLF
      Involuntary-Recluse Involuntary-Recluse 7 minutes ago
      99.9% is nonexistent past performance, .01% is the OTC.

      The OTC ain't coming back, the writing has been on the wall for some time IMHO...

      There have been ample bull markets in the OTC since 2014 for ASKH to attempt something/anything....

      Yet, for reasons
      ASKH
      janice shell janice shell 7 minutes ago
      How did the hatred of the Elite by the wingnuts produce a ticket with a billionaire and a Yale Law graduate?

      Don't forget that Vance also worked for a hedge fund.
      jaiguruji7 jaiguruji7 8 minutes ago
      LOL LOL!!!!! 🤡 🤡 🤡 getting worried too much. Hehehehhe!!!!
      DBMM
      mc73 mc73 9 minutes ago
      Another day passed is another step closer to IDE approval 🙏🤞
      RDGL
      Golden Cross Golden Cross 9 minutes ago
      Ok, do what you wish 2...
      CATV
      kevindenver kevindenver 9 minutes ago
      Anavex is a sponsor, thus they are getting exposure.

      https://fragilex.org/get-involved/international-fragile-x-conference/#agenda

      Dr. K is getting exposure there and not for Anavex, but for himself...
      AVXL

      Your Recent History

      LSE
      CEL
      Celadon Pharmaceuticals
      Delayed Upgrade Clock